bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-70-1420-04

Order Name:
PCR for STD (Vaginal swab)

 
Useful For:
Use for the detection of C. trachomatis (CT), N. gonorrhoeae (NG), M. genitalium (MG), M. hominis (MH), U. urealyticum (UU), U. parvum (UP), and T. vaginalis (TV) from urine and genital swab specimens.
 
Methodology:
Multiplex real-time polymerase chain reaction (PCR)
 
Test List In Profile:
Ureaplasma urealyticum
Neisseria gonorrhoeae
Mycoplasma hominis
Mycoplasma genitalium
Ureaplasma parvum
Chlamydia trachomatis

Trichomonas vaginalis
 
AliasesName:
PCR for Sexual transmitted disease (STD)
STD by PCR
Sexually transmitted infections (STI) assay
PCR for STI
 
 
 
Test Code:
090-70-1420-04

Order Name:
PCR for STD (Vaginal swab)

 
Collection Specimen Or Container:
Vaginal swab/ Universal Transport Media (UTM) 1 mL, 1 tube
 
Specimen Testing Type:
Vaginal swab/ Universal Transport Media (UTM) 1 mL, 1 tube
 
Sub Mission Container:
Universal Transport Media (UTM) tube
 
Specimen Stabillity:
Specimen Type Temperature Time
Swab specimen collected in UTM tube Refrigerated, 2oC to 8oC 1 week
 
 
 
Test Code:
090-70-1420-04

Order Name:
PCR for STD (Vaginal swab)

 
Method detail:
Multiplex real-time polymerase chain reaction (PCR)
 
Schedule:
Monday, Wednesday and Friday, at 09:00 a.m.
 
Turnaround Time:
Received specimen to reported within 3 days.
 
Performing Location:
Molecular biology & Genetics, Laboratory Department Tel.14168
 
Specimen Retention Time:
7 days
 
 
 
Test Code:
090-70-1420-04

Order Name:
PCR for STD (Vaginal swab)

 
 
Clinical Information:
The term sexually transmitted diseases (STDs) is used to refer to a variety of clinical syndromes caused by pathogens that can be acquired and transmitted through sexual activity. More than 30 bacterial, viral, and parasitic pathogens are transmissible sexually and constitute a group of infections called to as sexually transmitted infections (STIs). Some STIs can increase the risk of HIV acquisition three-fold or more. STIs can have serious consequences beyond the immediate impact of the infection itself, through mother-to-child transmission of infections and chronic diseases. Further complicating STI diagnosis is that different pathogens can cause similar symptoms, but the antibiotic treatment regimen may differ depending upon the pathogen. This complexity of issues makes simultaneous and accurate STI detection a major key to cost-effective patient care.
 
Reference Value:
Test Reference Value
Ureaplasma urealyticum Not detected
Neisseria gonorrhoeae Not detected
Mycoplasma hominis Not detected
Mycoplasma genitalium Not detected
Ureaplasma parvum Not detected
Chlamydia trachomatis Not detected
Trichomonas vaginalis Not detected
 
Interpretation:
  1. Reliability of the results depends on adequate specimen collection, storage, transport and processing procedure.
  2. The detection result is dependent on the number of organisms present in the specimen and may be affected by specimen collection methods, patient factors (i.e., age, history of STD, presence of symptoms), stage of infection and/or infecting pathogen strains.
  3. Ureaplasmas and M. hominis should be considered primarily as commensals when detected in the lower genital tract. Although the diagnosis of Ureaplasma spp. and M. hominis in cervical samples is important because these microorganisms could be pathogenic and could be associated with adverse pregnancy outcomes, postpartum sepsis, neonatal systemic inflammatory response syndrome and bronchopulmonary dysplasia.
  4. Interfering substances may affect the detection of this test therefore, the results must be used in conjunction with clinical presentation and other laboratory markers.
 
Clinical Reference:
Manufacturer’s package insert, AllplexTM STI Essential Assay, January 2019, Seegene, Inc. Seoul 138-050, Korea.